White will stay on as CEO of ABT after the AbbVie pharma spinoff—he knows that what remains of ABT will be the faster-growing and more exciting of the two successor companies.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”